| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Improved survival with bevacizumab in advanced cervical cancer.
|
N Engl J Med
|
2014
|
4.01
|
|
2
|
An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT).
|
Gynecol Oncol
|
2011
|
2.89
|
|
3
|
Incidence of venous thromboembolism after minimally invasive surgery in patients with newly diagnosed endometrial cancer.
|
Obstet Gynecol
|
2012
|
2.09
|
|
4
|
Management of uterine adenosarcomas with and without sarcomatous overgrowth.
|
Gynecol Oncol
|
2012
|
1.67
|
|
5
|
Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
|
Am J Surg Pathol
|
2009
|
1.62
|
|
6
|
The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered?
|
Int J Gynecol Cancer
|
2011
|
1.60
|
|
7
|
The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes.
|
Gynecol Oncol
|
2012
|
1.52
|
|
8
|
Impact of operative start time on surgical outcomes in patients undergoing primary cytoreduction for advanced ovarian cancer.
|
Gynecol Oncol
|
2012
|
1.47
|
|
9
|
Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study.
|
J Clin Oncol
|
2012
|
1.46
|
|
10
|
Ventral hernia following primary laparotomy for ovarian, fallopian tube, and primary peritoneal cancers.
|
Gynecol Oncol
|
2010
|
1.42
|
|
11
|
The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas.
|
Gynecol Oncol
|
2010
|
1.37
|
|
12
|
The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes.
|
Gynecol Oncol
|
2009
|
1.33
|
|
13
|
Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems.
|
J Clin Oncol
|
2009
|
1.27
|
|
14
|
Genetic analysis of the early natural history of epithelial ovarian carcinoma.
|
PLoS One
|
2010
|
1.25
|
|
15
|
Surgical and pathologic outcomes of fertility-sparing radical abdominal trachelectomy for FIGO stage IB1 cervical cancer.
|
Gynecol Oncol
|
2008
|
1.20
|
|
16
|
Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma.
|
Gynecol Oncol
|
2008
|
1.16
|
|
17
|
A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.
|
Gynecol Oncol
|
2009
|
1.14
|
|
18
|
Comparison of robotic and laparoscopic hysterectomy for benign gynecologic disease.
|
Obstet Gynecol
|
2014
|
1.12
|
|
19
|
Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors.
|
Gynecol Oncol
|
2009
|
1.11
|
|
20
|
A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma.
|
Cancer
|
2011
|
1.06
|
|
21
|
Surgical resection of recurrent endometrial carcinoma.
|
Gynecol Oncol
|
2006
|
1.01
|
|
22
|
Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.
|
Int J Gynecol Cancer
|
2014
|
1.01
|
|
23
|
High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes.
|
Gynecol Oncol
|
2012
|
0.98
|
|
24
|
A prospective study of the feasibility and acceptability of a Web-based, electronic patient-reported outcome system in assessing patient recovery after major gynecologic cancer surgery.
|
Gynecol Oncol
|
2012
|
0.97
|
|
25
|
The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma.
|
Gynecol Oncol
|
2011
|
0.96
|
|
26
|
A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer.
|
Oncologist
|
2009
|
0.96
|
|
27
|
Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer.
|
Gynecol Oncol
|
2009
|
0.95
|
|
28
|
Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
|
Gynecol Oncol
|
2011
|
0.94
|
|
29
|
External validation of a nomogram predicting overall survival of patients diagnosed with endometrial cancer.
|
Gynecol Oncol
|
2012
|
0.90
|
|
30
|
Prognostic value of lymph node ratio and clinicopathologic parameters in patients diagnosed with stage IIIC endometrial cancer.
|
Obstet Gynecol
|
2012
|
0.90
|
|
31
|
p53 overexpression in morphologically ambiguous endometrial carcinomas correlates with adverse clinical outcomes.
|
Mod Pathol
|
2009
|
0.90
|
|
32
|
Video-assisted thoracic surgery (VATS) evaluation of pleural effusions in patients with newly diagnosed advanced ovarian carcinoma can influence the primary management choice for these patients.
|
Gynecol Oncol
|
2009
|
0.88
|
|
33
|
Classification and regression tree (CART) analysis of endometrial carcinoma: Seeing the forest for the trees.
|
Gynecol Oncol
|
2013
|
0.87
|
|
34
|
Expression of cancer-testis antigens in endometrial carcinomas using a tissue microarray.
|
Mod Pathol
|
2005
|
0.87
|
|
35
|
Advances in the management of endometrial carcinoma.
|
Gynecol Oncol
|
2011
|
0.87
|
|
36
|
Expanding the indications for radical trachelectomy: a report on 29 patients with stage IB1 tumors measuring 2 to 4 centimeters.
|
Int J Gynecol Cancer
|
2013
|
0.86
|
|
37
|
Histological features associated with occult lymph node metastasis in FIGO clinical stage I, grade I endometrioid carcinoma.
|
Histopathology
|
2013
|
0.85
|
|
38
|
Electrocautery-associated vascular injury during robotic-assisted surgery.
|
Obstet Gynecol
|
2012
|
0.84
|
|
39
|
Pelvic insufficiency fractures in patients with cervical and endometrial cancer treated with postoperative pelvic radiation.
|
Gynecol Oncol
|
2012
|
0.83
|
|
40
|
Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion.
|
Gynecol Oncol
|
2013
|
0.81
|
|
41
|
Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer.
|
Gynecol Oncol
|
2008
|
0.81
|
|
42
|
Incidence of lymph node and adnexal metastasis in endometrial stromal sarcoma.
|
Gynecol Oncol
|
2011
|
0.79
|
|
43
|
Clinicopathologic analysis of low-stage sporadic ovarian carcinomas: a reappraisal.
|
Am J Surg Pathol
|
2013
|
0.78
|
|
44
|
Potential pitfalls of the rapid uptake of new technology in surgery: can comparative effectiveness research help?
|
J Clin Oncol
|
2012
|
0.77
|
|
45
|
Invasion patterns in stage I endometrioid and mucinous ovarian carcinomas: a clinicopathologic analysis emphasizing favorable outcomes in carcinomas without destructive stromal invasion and the occasional malignant course of carcinomas with limited destructive stromal invasion.
|
Mod Pathol
|
2005
|
0.77
|
|
46
|
Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173.
|
Gynecol Oncol
|
2012
|
0.77
|
|
47
|
Intraoperative hypothermia during primary surgical cytoreduction for advanced ovarian cancer: risk factors and associations with postoperative morbidity.
|
Gynecol Oncol
|
2013
|
0.77
|
|
48
|
Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment.
|
Int J Gynecol Cancer
|
2013
|
0.76
|
|
49
|
Tumoral displacement into fallopian tubes in patients undergoing robotically assisted hysterectomy for newly diagnosed endometrial cancer.
|
Int J Gynecol Pathol
|
2013
|
0.76
|
|
50
|
Micropapillary pattern in newly diagnosed borderline tumors of the ovary: what's in a name?
|
Oncologist
|
2011
|
0.75
|
|
51
|
Optimal study design and the CONSORT guidelines.
|
Fertil Steril
|
2005
|
0.75
|
|
52
|
A Comparison of the Detection of Sentinel Lymph Nodes Using Indocyanine Green and Near-Infrared Fluorescence Imaging Versus Blue Dye During Robotic Surgery in Uterine Cancer.
|
Int J Gynecol Cancer
|
2017
|
0.75
|
|
53
|
Staging Lymphadenectomy in Patients With Clear Cell Carcinoma of the Ovary.
|
Int J Gynecol Cancer
|
2016
|
0.75
|
|
54
|
In reply.
|
Obstet Gynecol
|
2013
|
0.75
|
|
55
|
Grading uterine endometrioid carcinoma: a proposal that binary is best.
|
Am J Surg Pathol
|
2014
|
0.75
|
|
56
|
The highs and lows of targeted therapies.
|
Oncology (Williston Park)
|
2015
|
0.75
|
|
57
|
Low-Stage High-Grade Serous Ovarian Carcinomas: Support for an Extraovarian Origin.
|
Int J Gynecol Pathol
|
2016
|
0.75
|
|
58
|
Radical Trachelectomy for the Treatment of Early-Stage Cervical Cancer: A Systematic Review.
|
Obstet Gynecol
|
2020
|
0.75
|
|
59
|
Parenchymal splenic metastasis is an independent negative predictor of overall survival in advanced ovarian, fallopian tube, and primary peritoneal cancer.
|
Gynecol Oncol
|
2012
|
0.75
|
|
60
|
Improving safety in robotic surgery: intraoperative crisis checklist.
|
J Surg Oncol
|
2013
|
0.75
|